GE HealthCare Names J&J Exec Will Song as President & CEO, China

GE HealthCare announced that Yihao Zhang, president and CEO, China, will retire from the company on July 1, 2025. Will Song, a Johnson & Johnson veteran of over two decades, was named the company’s new president and CEO, China, and will join the company on April 1, 2025.

Zhang joined GE HealthCare in 2019 and is responsible for the company’s strategic development and operations in China. He has doubled innovation investment within five years, expanded the company’s manufacturing footprint in Beijing, Wuxi, Tianjin, and Shanghai, and built two new manufacturing sites in Chengdu and Shenzhen.

“Yihao has proven himself to be a humble, energetic, people-focused leader who embraced our company culture, strategy and purpose. He has made an indelible mark on our colleagues and the industry,” said Peter Arduini, president and CEO, GE HealthCare. “I want to personally thank Yihao for his leadership and contributions through the years, and for positioning GE HealthCare as a leading innovator in China. I wish him a healthy and happy retirement. Looking ahead, I am confident that Will’s stellar reputation and in-depth knowledge of the China market, along with his robust relationships with key stakeholders and deep understanding of our customer base, will help enhance our position in China and move the region forward to effectively deliver on the future of healthcare.”

Song served as Johnson & Johnson’s global senior VP and China chairman. He led the China Presidents’ Council to advance J&J’s journey of innovation in China across its MedTech and Innovative Medicine businesses. He joined J&J in 2003 and held various global positions with increasing responsibilities.

He was also vice chairman of the China Association of Medical Devices Industry, vice president of the China Association of Enterprises with Foreign Investment, and vice chairman, Shanghai Enterprises Directors Association.